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ABSTRACT
Flaviviruses are positive-strand single-stranded RNA viruses that are known to
form pseudo-knot RNA structures that halt the progression of 5’3’ exonuclease Xrn1.
We show that these viral Xrn1-resistant structures (xrRNAs) can be used to protect
specific homologously-expressed messenger RNAs from 5’3’ degradation. We
investigated the effects of addition of xrRNAs, artificially-installed into the intergenic
region of bicistronic mRNA reporters, in the observed levels of protein expression in
yeast. The reporters also contain an internal ribosome entry site from the cricket paralysis
virus (CrPV IRES) to allow for cap-independent translation of the decay-protected gene,
LacZ, encoding the enzyme β-galactosidase. Through the use of primer extension, βgalactosidase assay, and western blots, the results indicate that the partially-decayed
RNAs are successfully translated, and that addition of xrRNAs results in a 30-50 fold
increase in measured enzymatic activity and an accumulation of decay-resistant
transcripts in the cell.
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CHAPTER ONE: INTRODUCTION

1.1

Eukaryotic mRNA
The central dogma of molecular biology paints a simple picture of the flow of

genetic information in the cell: DNA is used as a blueprint to make messenger RNA
(mRNA), which in turn gets translated into protein. In reality, the transfer of genetic
information follows a dynamic system in which the flow of information is heavily
regulated in a bilateral fashion (Vihervaara et al., 2008). Cells have evolved complex and
precise regulatory systems to alter the rate of gene expression in response to internal or
external stimuli with the use of enzymes and regulatory molecules. An important aspect
of gene expression is the regulation of mRNA levels in the cell, which is highly
dependent on the rate of two opposing processes: transcription and decay (Alonso, 2012).
Decay of mRNA transcripts can occur via different redundant pathways in yeast
(Parker, 2012). In the 5’3’ direction, the major exonuclease responsible for mRNA
decay is the enzyme XRN1, which recognizes a 5’ monophosphate left behind after the 5’
cap is removed by a decapping enzyme (Geerlings et al., 2000). Viral pseudoknot RNA
1

structures known as xrRNAs have been shown to resist decay by XRN1 by presenting the
enzyme with a mechanical barrier. These XRN1-resistant structures are known to protect
fragments of the viral genome from degradation, resulting in the accumulation of decayresistant fragments that have been linked to increased pathogenicity in the infected cells
(Chapman et al., 2014a, 2014b, Akiyama et al., 2016). By studying these decay-resistant
structures, it may be possible to gain insight on gene expression regulatory mechanisms,
as well as possibly discovering ways of combatting and/or attenuating certain kinds of
viral infections. xrRNAs can potentially be used in molecular biology to protect desired
mRNAs from degradation, which should result in increased protein synthesis after the
genes encoded within those decay-resistant mRNA fragments are translated. This work
concentrates on investigating the effects of addition of xrRNAs to previouslycharacterized yeast reporters by qualitative and quantitative analysis of the protein and
mRNA content of the resulting cells.

1.1.1

Transcription
The lifecycle of an mRNA molecule begins with transcription. By definition,

transcription is the formation of an RNA molecule from a DNA template and requires the
use of a DNA-dependent RNA polymerase. In eukaryotes, the main enzyme responsible
for mRNA transcription in the nucleus is RNA polymerase II (RNAP II). Transcription
begins when RNAP II is recruited to the promoter region of a protein-coding gene with
the help of several general transcription factors (GTFs). A promoter region is a sequence
element in the DNA that is recognized by specific transcription factors as a binding site,
2

triggering a cascade of events that lead to transcription initiation. Promoters can be
constitutively active (e.g. house-keeping genes), or inducible, in which genes are turned
on or off in response to changes in cellular conditions. An example of an inducible
promoter is the galactose promoter that regulates the transcription of genes required for
galactose catabolism, which ensures that the genes are transcribed if (and only if) they are
required for cell growth and survival (Douglas and Condie, 1954; Douglas and
Hawthorne, 1964). Since glucose is a repressor of the galactose promoter, and galactose
is an activator, the genes are only transcribed in the absence of glucose and presence of
galactose. Otherwise, the cells rely on glucose catabolism, which provides more ATP per
molecule and is thus the favorable catabolite. The use of a galactose-inducible promoter
in cellular biology allows for a higher control of experimental conditions, since the genes
can easily be turned on or off as needed by simply switching the growth media.
Five GTFs have been shown to be essential for transcription and are highly
conserved in all eukaryotes: TFIID, TFIIB, TFIIF, TFIIH, and TFIIE (Orphanides et al,
2019). For RNAP II-mediated transcription, a subunit of TFIID (TBP, or TATA-BindingProtein) recognizes and binds to the TATA element present in a great variety of
promoters. TFIIB then recognizes the TFIID-promoter complex and binds, followed by
binding of TFIIE, TFIIH and TFIIA to complete the preinitiation complex. The DNA
strands are separated around the promoter region (promoter melting), providing the
single-stranded template necessary for RNAP II to begin mRNA synthesis. Transcription
begins with extensive phosphorylation of the carbon-terminal domain (CTD) of RNAP II
by TFIIH, and formation of the first phosphodiester bond between two RNA bases.
3

1.1.2

Processing and Transport
Processing of the RNA transcript into a mature mRNA occurs cotranscriptionally

with three major reactions: capping, splicing, and polyadenylation. This process begins
when the emerging RNA transcript is about 20-30 nucleotides long by the addition of a 5’
cap. This occurs in three steps: 1) the triphosphate of the first RNA nucleotide is
hydrolyzed by RNA triphosphatase, resulting in a bisphosphate group, 2) A GMP is
added to the bisphosphate via a 5’-5’ linkage by a guanyltransferase, and 3) The N7
position in the added GMP is methylated by a methyltransferase, resulting in the 5’ 7methylguanylate cap (m7G) (Proudfoot et al, 2002). The unusual 5’-5’ linkage of the m7G
cap provides stability to the RNA molecule (Beelman and Parker, 1995) and is
recognized by the cap-binding complex (CBC), which remains bound to the mRNA until
it has been exported to the cytoplasm.
In general, eukaryotic genes are made up of coding regions (exons) interrupted by
noncoding regions (introns). Splicing is the removal of introns and merging of exons into
a single open-reading frame that can be subsequently translated into protein. Splicing
occurs via two reactions (each followed by transesterification): 1) Nucleophilic attack of
the 2’OH on the branchpoint adenosine onto the 5’ end of exon 1, resulting in a lariat
intermediate and a free exon 1, and 2) Nucleophilic attack of 2’OH of exon 1 ono the 5’
end of exon 2, resulting in the spliced pre-mRNA and free intron (More and Sharp,
1993). These reactions are facilitated by the spliceosome, made up of small nuclear
RNAs (U1, U2, U4, U5, and U6) and their associated proteins (For review, see Kramer,
1996).
4

Most mRNAs contain a 3’ end made up of about 250 adenosine residues, known
as the poly(A) tail. Before the poly(A) tail is added, the pre-mRNA is cleaved
downstream from the polyadenylation signal, which is a highly conserved hexamer of
sequence AAUAAA, followed by a downstream sequence element (DSE) composed of a
U- or GU-rich motif. Cleavage and polyadenylation specificity factor (CPSF) binds
directly to the hexameric polyadenylation signal and is the main enzyme responsible for
cleavage of the pre-mRNA approximately 10-30 nucleotides downstream from its
binding site (usually between the hexamer and DSE). Cleavage usually occurs before
transcription termination, and cleavage stimulation factor (CStF) binds to both the RNA
and RNAP II, signaling it to release the transcript (Glover-Cutter, 2008). Once the premRNA has been cleaved, the enzyme polyadenylate polymerase (poly(A) polymerase)
catalyzes the addition of single adenosine monophosphate units to the 3’ end, until the
tail is approximately 250 nucleotides long (For review, see Wahle and Ruegsegger,
1999).
Once capped, spliced, and polyadenylated, mature mRNAs can be transported
from the nucleus to the cytoplasm. Mature mRNAs remain bound to several proteins,
forming mature messenger ribonucleoproteins (mRNPs). The associated proteins serve to
stabilize the RNA, and direct it to the cytoplasm. Among these proteins, the CBC plays a
crucial role in transport through the nuclear pore complex, along with the DEAD box
protein, Dbp5 (Hamm, 1990; Rocak and Linder, 2004). Once in the cytoplasm, the
translation process can begin.
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1.1.3

Translation
A mature mRNP consists of at least one protein-coding gene, also called open

reading frame (ORF), flanked by 3’ and 5’ untranslated regions (UTRs), protected by a 5’
cap and 3’ poly(A) tail, and complexed with several proteins. The translation of mRNAs
primarily occurs by a 5’ cap-dependent pathway: initiation of translation involves the
interaction of the ribosome, among other key proteins, with the 5’ cap and 5’ UTR of the
mRNA. Proteins importin-α and importin-β are responsible for exchanging the CBC with
the cap-binding protein eIF4F (eukaryotic Initiator Factor 4F), which mediates the
initiation of the standard cap-dependent translation (Sato and Maquat, 2009;
Gonatopoulos-Pournatzis and Cowling, 2013).
Eukaryotic ribosomes (80S) are composed of two subunits: the small subunit
(40S) and the large subunit (60S). The first step in translation initiation involves the
binding of the initiator tRNA (Met-tRNAiMet) to the P site of the small ribosomal subunit.
This is achieved with the help of eIF2, which complexes with the tRNA, the 40S subunit
and GTP, which is required for translation initiation (Sonenberg and Dever, 2003). The
resulting eIF2•GTP•Met–tRNAiMet ternary complex (FIGURE 1), joined by the 40S
subunit, eIF1, eIF1A, eIF3 and eIF5 form the 43S preinitiation complex (PIC) (Algire et
al., 2002). The PIC is recruited by eIF4F. eIF4F consists of three subunits: eIF4A, eIF4E
and eIF4G. eIF4E is responsible for binding to the 5’ cap, while eIF4A serves as an
ATPase and ATP-dependent RNA helicase (Sonenberg, 1996). eIF4G is a scaffold
protein that also binds eIF3, which associates with the 40S ribosomal subunit (Pain,
1996). The poly(A)-binding protein (PABP) binds to the poly(A) tail, which has been
6

shown to be essential for effective translation initiation (Jacobson, 1996; Sachs et al,
1997). In yeast, PABP has been shown to associate with eIF4G (Tarun and Sachs, 1996).
In poly(A) tail-dependent translation, the mRNA circularizes following the closed loop
model, in which the 3’ end of the mRNA loops around to the 5’ end (Kahvejian, 2001;
Tarun and Sachs, 1996).

FIGURE 1. Assembly of the eukaryotic 80S ribosome capable of translation
initiation. The eIF2•GTP•Met–tRNAiMet ternary complex is vital for proper formation of
the cap-dependent translation initiation complex (Figure adapted from Pavitt & Proud,
2009).
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Once formed, the PIC is recruited to the 5’ cap of the mRNA and, once bound,
scans the 5’ UTR of the mRNA in the 5’3’ direction until it locates the start codon,
AUG (Hinnebusch, 2011). Once the start codon is reached, the PIC releases eIF1, which
triggers a change in conformation of the complex and GTP hydrolysis, releasing an
inorganic phosphate. eIF5, the GTPase responsible for this hydrolysis reaction, and
eIF2•GDP are subsequently released (Maag et al, 2005). The eukaryotic initiation factors
1A and 5B (a second GTPase) mediate the assembly of the 60S ribosomal subunit,
forming the 80S initiation complex. Binding of the 60S subunit triggers GTP hydrolysis
by eIF5B, which leads to conformational changes in the complex, resulting in release of
eIF5B (Pestova et al, 2000). Finally, eIF1A is released (Acker et al, 2009), resulting in a
fully-assembled 80S ribosome capable of protein synthesis (For comprehensive review of
translation initiation, see Aitken and Lorsch, 2012).
Elongation begins with the initiator tRNA bound to the P (peptidyl-tRNA) site of
the 80S ribosome. The eukaryotic elongation factor 1α (eEF-1α), which binds to GTP and
the aminoacyl-tRNA, directs the binding of the corresponding amino acid to the next
codon in the mRNA sequence, located at the A site. When the correct match has been
made, GTP is hydrolyzed, eEF-1α •GDP is released, and the aminoacyl-tRNA is placed
at the A site. The peptidyl transferase center located in the 60S subunit can then catalyze
peptide bond formation between the two amino acids in the P and A sites. The initiator
methionine is released from the P site, transferring the nascent polypeptide onto the A
site. The mRNA is shifted down one codon, leaving the deaminoacylated initiator tRNA
at the E (exit) site, and the tRNA containing the polypeptide chain at the P site. The
8

translocation step is mediated by eEF-2, and also requires GTP hydrolysis. The initiator
tRNA exits and a new aminoacyl-tRNA enters at the A site. This cycle is repeated for the
rest of the coding region of the mRNA (Merrick, 1992), until one of three stop codons is
reached (UAA, UGA, or UAG). Termination of translation begins when the stop codon is
recognized by eukaryotic release factor 1 (eRF1). After eRF3 hydrolyzes GTP, eRF1
releases the polypeptide from the tRNA located in the P site (Hellen, 2018). The posttermination complex is subsequently disassembled, freeing all the components and
allowing them to enter another cycle of translation.

1.1.3.1 Eukaryotic Versus Prokaryotic Translation
There are important distinctions between eukaryotic and prokaryotic mRNAs. As
explained above, in eukaryotes, the processes of transcription and translation are
separated in space and time. Prokaryotic cells, on the other hand, do not contain a nucleus
and therefore do not require transport of mRNAs to the cytoplasm. In prokaryotes, the
processes of transcription and translation do not only occur in the same place, but also
can occur simultaneously. Prokaryotic translation can begin before the process of
transcription is complete, with ribosomes having the capability of binding to nascent
mRNAs. In comparison to eukaryotic mRNAs, prokaryotic mRNAs require almost no
post-transcriptional modifications and have a significantly lower lifetime.
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1.1.3.2 Internal Ribosome Entry Sites (IRES)
Another important distinction is the number of genes encoded in each mRNA.
Eukaryotic mRNAs are typically monocistronic, indicating that each mRNA contains a
single ORF, encoding for a single polypeptide. In contrast, prokaryotic mRNAs can
contain multiple ORFs. Only the first ORF in a polycistronic mRNA can be translated via
cap-dependent translation, since the ribosome-mRNA interaction is broken once the
ribosome reaches the stop codons present at the 3’ end of the first ORF. An internal
ribosome entry site (IRES) is a cis-acting RNA element that, when present upstream from
a coding region, can be recognized by and act as a binding site to a ribosome, thus
allowing for cap-independent translation. IRES structures were first discovered in
picornaviral mRNAs (Jang et al., 1988; Pelletier and Sonenberg, 1988), and were
originally believed to function exclusively in prokaryotes (Kozak, 1979; Kanarska et al.,
1981), since eukaryotic ribosomes were reportedly unable to bind circular mRNAs. The
picornaviral IRES was found to be a 450-nucleotide structure located at the 5’UTR of the
viral genome (Jackson et al., 1990). Initiation of translation via an IRES differs from the
canonical mechanism, since the ribosome binds directly to the entry site, rather than
scanning for the start codon after binding to the 5’ end. The notion that IRES structures
could only function in prokaryotes was disproven when it was shown that insertion of this
structure into the intron of bicistronic eukaryotic mRNAs could mediate translation
initiation via internal entry of the ribosomes (Jang et al., 1988; Pelletier and Sonenberg,
1988). Up to date, a large number of non-prokaryotic IRES structures have been found,
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both in viral and eukaryotic mRNAs encoding for a wide range of proteins (For review,
see Hellen and Sarnow, 2019).

1.1.3.2.1

Mechanisms of Internal Ribosomal Entry

Current knowledge suggests that there is no universal IRES structure or
mechanism of internal ribosomal entry. No important parallels have been made in respect
to size, sequence, or structure between all known IRES elements. So far, three
mechanisms of translation initiation via internal ribosomal entry have been differentiated.
The first mechanism is observed in members of the Picornaviridae family. Although
IRES elements have been discovered for all known members of this viral family, there
are at least three distinct structural motifs observed, with members of each genus
displaying similar characteristics (Brown et al., 1991; Borman and Jackson, 1992; Hinton
and Crabb, 2001; Bakhshesh et al., 2008). Despite their structural features, all IRES
elements of the Picornaviridae family recruit the ribosome with the help of translation
initiation factors and RNA binding proteins, including eIF4G, the poly(A) binding
protein (PABP) and the eIF3/eIF2•GTP•Met–tRNAiMet ternary complex. In short, eIF4G
and PABP interact around the IRES elements, leading to a pseudo-circularization of the
mRNA that is similar to that observed in cap-dependent translation (Martinez-Salas et al.,
2015). In contrast to the factor-dependent mechanism observed in the Picornaviridae
family, the IRES from hepatitis C virus (HCV) is able to bind the 40S ribosomal subunit
in the absence of any initiator factor. The HCV IRES is a 410-nucleotide-long stem-loop
secondary structure that consist of most of the viral 5’ UTR and interacts directly with the
11

40S subunit, which in turn binds to eIF3. The start codon has been shown to be located
on loop IV of the structure, right on (or very near) the P-site of the bound ribosomal
subunit (Pestova et al., 1998).

1.1.3.2.2

Translation Initiation without Initiator tRNA (The CrPV IRES)

The third method of internal ribosomal entry, discovered in the cricket paralysis
virus (CrPV), is not only independent of initiator factors in order to achieve IRES•40S
subunit complex formation, but also does not require eIF2, an initiator tRNA, or GTP
hydrolysis in order to achieve the fully-functional IRES•80S ribosome complex (Hellen
and Sarnow, 2019). The CrPV IRES has been shown to bind the 40S ribosomal subunit,
then recruit the 60S subunit directly, initiating translation from the A site (rather than the
P site) of the ribosome (Wilson et al., 2000). Internal translation initiation by the CrPV
IRES also differs from the canonical mechanism in that the first amino acid in the
resulting polypeptide is not methionine, but either alanine or glutamine (Sasaki and
Nakashima, 1999).
The CrPV IRES is 192 nucleotides long, commonly forming an extensive triplenested pseudoknot (Kanamori and Natashima, 2001; Thompson and Gulyas, 2001;
Schüler et al., 2007). It contains a smaller pseudoknot structure (42 nucleotides long) at
the 3’ end that has been shown to be essential for translation initiation, since internal
translation initiation has been disrupted in mutants that exhibit improper pseudoknot
formation (FIGURE 2) (Sasaki and Nakashima, 1999; Domier et al., 2000, Wilson et al,
2000). The pseudoknot is immediately followed by the coding triplet, which is either
12

CrPV IRES
CrPV IRES mutations
18S ribosomal RNA
25S ribosomal RNA
60S ribosomal protein

FIGURE 2. Stereo view of ribosome-bound CrPV IRES structure (PDB 2NOQ,
adapted from Schuler et al., 2007). Mutations that prevent formation of the small 3’end
pseudoknot formation and inhibit internal ribosomal initiation are highlighted in yellow.

GCU or GCA in all CrPV-like IRESs that have been studied. Helical regions of the
CrPV-like IRES elements are believed to play a key structural role, since there is high
sequence specificity in these regions (Hellen and Sarnow, 2019). The mechanism through
which the CrPV IRES recruits the ribosome is believed to be an unprecedented stance of
tRNA- and mRNA-mimicking, since recent cryo-microscopy structures of an
IRES•Ribosome•aminoacyl-tRNA complex show a conformation in which the IRES
binds to the E site of the ribosome mimicking the acceptor stem of a tRNA (Pisareva et
al., 2018). The structures shows a doubly-translocated IRES structure with the
aminoacyl-tRNA occupying the P site. This suggests that the IRES is not only able to
trigger translation initiation without the need for the initiator tRNA, but that it is also able
to translocate twice (lacking prior peptide-bond formation), leaving the ribosome ready
13

for elongation. Thus, the IRES element can mimic mRNA in order to recruit the 40S
subunit of the ribosome, and mimic tRNA in order to initiate protein synthesis. This
double-mimicking mechanism allows the CrPV IRES to bind the ribosome and prime it
for translation elongation, without the need for eukaryotic initiation factors.

1.1.4

mRNA Half-Lives and Stability
Once an mRNA molecule has been transcribed, it has a specific lifetime after

which it is broken down into individual bases, which can be subsequently recycled into
new mRNAs. Mammalian mRNAs have been found to have half-lives ranging from a
few minutes to over 24 hours (Sharova et al., 2009). Even mRNAs with very short halflives can be translated more than once. Once an 80S ribosome has assembled at the 5’
end of the mRNA and translation has initiated, the ribosome will travel in the 5’3’
direction along the mRNA, decoding every codon and adding the corresponding amino
acid to the growing peptide chain, until it reaches a stop codon. This frees up the 5’ end,
enabling a second ribosome to assemble, and so on, resulting in several ribosomes loaded
onto a single mRNA. Furthermore, following the closed-loop model, once the ribosome
reaches the stop codon at the 3’ end of the mRNA, the 5’ end is in close proximity,
allowing for the newly released ribosome to bind again and begin a new round of
translation. In human cells, the protein-to-mRNA ratio has been found to vary greatly,
ranging from 1x102 to 1x108, with most ratios ranging over more than two orders of
magnitude (Eraslan et al., 2019).
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An important factor affecting mRNA lifetime is its stability, which in turn can be
determined by its sequence and structure (Ross, 1995). Primary and secondary structure
of an mRNA are cis-determinants of its stability. These cis-determinants include the
poly(A) tail, 5’ and 3’ UTRs, and the mRNA coding region. In general, these cisenhancers of stability are sequences that can basepair to form a more stable secondary
structure; even the smallest changes in secondary structure have been found to have the
ability to influence mRNA half-lives (Weiss and Liebhaber, 1994). There are many other
factors that determine the stability of an mRNA, including its translation rate, cellular
location and environment, as well as the presence of regulatory factors. Trans-acting
factors include RNA-binding proteins that shield mRNAs from degradation, including
PAPB (Ross, 1995).

FIGURE 3. The concentration of mRNAs in the cell is highly dependent on the
rates of two opposing processes: transcription and mRNA decay. Similarily, the major
factors affecting protein concentrations are: mRNA abundance, and rates of translation
and protein degradation.
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1.1.5

mRNA Turnover
After an mRNA has fulfilled its biological role, it must be degraded in order to

prevent buildup of products and intermediates in the cell (FIGURE 3). As previously
discussed, eukaryotic mRNAs are stabilized by interactions of the 5’ cap and the poly(A)
tail with eIF4G and PAPB. The poly(A) tail is progressively shortened over time
(Sheiness and Dernell, 1973). The process of mRNA degradation begins once the length
of the poly(A) tail is approximately 10 nucleotides long, making the oligo(A) tail too
short to maintain a physical interaction with PAPB (Decker and Parker, 1993; Muhlrad
and Parker, 1992; Muhlrad et al., 1994). After this, the mRNA is degraded by one of two
redundant pathways: the exosome-mediated 3’5’ pathway, or in the decappingdependent 5’3’ pathway. In the 3’5’ pathway, the unprotected 3’ end is attacked by
the exosome, which is a large complex of 3’5’ exoribonucleases (Mitchell and
Tollervey, 2003; Garneau et al., 2007).
In the 5’3’ decay pathway, the shortening of the poly(A) tail, which is thought
to in turn destabilize the cap-binding complex, is followed by decapping. The main
enzyme responsible for decapping in yeast is Dcp1p, which is believed to recognize the
mRNA substrate by interacting with both the 7-methyl group on the cap structure and the
RNA portion of the mRNA (LaGrandeur and Parker, 1998; Caponigro and Parker, 1996).
Removal of the m7G cap exposes a 5’ monophosphate which is the substrate for the
enzyme Xrn1 (Hsu and Stevens, 1993; Muhlrad et al., 1994). The exonucleolytic activity
of Xrn1 continues in the 5’3’ direction, removing one nucleotide at a time and
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exposing a new 5’ monophosphate each time, until the entire mRNA is degraded
(FIGURE 4).

FIGURE 4. Overview of 5’3’ mRNA decay pathway. The mRNA is committed
to decay after progressive deadenylation of the poly(A) tail results in a short oligo(A) tail.
Degradation continues by removal of the m7G cap by a decapping enzyme, which
exposes a 5’ monophosphate that is the substrate for the exoribonuclease, XRN1. XRN1
is the major 5’3’ exoribonuclease and completely degrades the remainder of the
mRNA sequence by cleaving off one nucleotide at a time.
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1.2

Partially-Decayed RNAs

1.2.1

Flaviviridae and Sub-Genomic RNAs
Flaviviruses are pathogenic plus-sense single-stranded RNA viruses that include

the West Nile virus, Zika virus, and yellow fever virus (Westaway, 1985). Upon
infection, flaviviruses utilize the host’s cellular enzymes in order to replicate their
genomic RNA. In addition, this process also generates noncoding RNA’s called
subgenomic flavivirus RNAs (sfRNAs) that are linked to increased pathogenicity
(Pijlman et al., 2008; Liu et al., 2014). These sfRNAs are now known to be the result of
incomplete decay by the exonuclease Xrn1 (Jones et al., 2012). This is due to the
formation of pseudo-knot structures found in the 3’ untranslated region of the viral
genome (3’UTR), which halt the progression of Xrn1 in the 5’3 direction (Chapman et
al., 2014a, 2014b, Akiyama et al., 2016), protecting any downstream genetic material
from degradation in that direction. The pseudoknot is composed of a three-helix junction,
through which the 5’ end is threaded, thus providing a mechanical barrier against Xrn1’s
exonucleolytic activity (FIGURE 5). These Xrn1-resistant structures (xrRNAs) can
potentially be used to target certain genes from degradation and are expected to increase
protein synthesis of such genes.

1.3

S. cerevisiae as a Model Organism
Yeast are unicellular eukaryotes that can reproduce either by sexual or asexual

reproduction. Being one of the simplest eukaryotic organisms, yeast make popular model
organisms for laboratory studies. The baker’s or budding yeast, Saccharomyces
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cerevisiae, is one such model organism. The S. cerevisiae genome was the first
eukaryotic genome to be fully sequenced (Goffeau et al., 1996) and is very well
characterized. S. cerevisiae cells are easy to grow and maintain, due to their short
generation time and flexibility to adjust to changing environmental conditions.
Furthermore, their genome is easily manipulated and a full collection of ORF knockouts
exists (Shoemaker et al., 1996; Chu and Davis, 2008), making S. cerevisiae an ideal
candidate for molecular biology studies.

FIGURE 5. ZIKV xrRNA front and side views. 5’ end (blue) threaded through
the center of a 3-helix junction (3’ labeled red). The pseudoknot forms a mechanical
barrier which prevents progression of the 5’3’ exonuclease XRN1 (PDB 5TPY,
adapted from Akiyama et al., 2016).
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1.3.1

S. cerevisiae Genomics
The S. cerevisiae genome is 12,068 kilobases long and encoded 5885 proteins,

140 ribosomal RNAs, 40 small nuclear RNAs, and 275 transfer RNAs, all found within
the yeast’s 16 chromosomes (Goffeau et al., 1996). The reference genome is S288C,
which is stored in the Saccharomyces Genome Database (https://www.yeastgenome.org)
and has a genotype of MATα SUC2 gal2 mal2 mel flo1 flo8-1 hap1 ho bio1 bio6 (See
below) (Mortimer and Johnston, 1986).
Cells can be either haploid or diploid, and both types of cells can reproduce
asexually by mitosis through budding, a process through which a daughter cell buds off a
mother cell. Haploid cells can also reproduce sexually by mating with cells of the
opposite mating type. The two different type of cells, a and α, produce mating
pheromones called a-factor and α-factor, respectively. Each mating type can only
respond to the opposite mating pheromone, and the a-type cells respond to the presence
of the a-factor by growing a projection called a shmoo toward the source of the mating
factor. In contrast, diploid cells can undergo meiosis and sporulation under conditions of
stress, producing four haploid spores, two of each mating type, which can subsequently
reproduce sexually (For review, see Duina et al., 2014; Billard et al., 2012).
By convention, yeast gene symbols contain three italic lowercase letters followed
by an Arabic number of the identifying mutation, and uppercase identifies a dominant
gene while a lowercase identifies a recessive gene. Alleles are listed as the gene symbol,
followed by a hyphen and an italic Arabic number. Alleles that have been altered
recombinantly are listed by the gene symbol followed by a specification on the type of
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alteration performed: (::) for a disruption, (-Δ) for a deletion, and (Δ::) for a replacement.
Proteins are written as the gene symbol, non-italicized, with the first letter uppercased,
and followed by the suffix “p”. Phenotypes are listed as the non-italic three letters of the
gene symbol (first letter uppercase), followed by a superscript “+” sign for wild-type and
“-” sign for mutant. When listing the genotype, the mating type loci are normally listed
first, followed by the gene symbols of the mutated and recombinant genes (Cherry,
1998).

1.3.2

Auxotrophy as a Selective Marker
Auxotrophy refers to the inability of a particular organism to synthesize a

metabolite needed for its growth and reproduction. By definition, the wild-type (WT)
strain is a prototroph, indicating that it can synthesize all the nutrients required for its
survival. Through a mutation in a key gene, a new mutant strain can be created that
enables for auxotrophic selection. For example, the ura3-52 mutation, caused by an
insertion of the transposable element Ty into the coding region of the URA3 gene
encoding for Orotidine 5'-phosphate decarboxylase (ODCase), transforms the mutant
cells into uracil auxotrophs (Rose and Winston, 1984; Flynn and Reece, 1999). If a
plasmid containing the URA3 ORF is used to transform these auxotrophs, only the cells
that were successfully transformed with the plasmid will be able to grow in minimal
media lacking the amino acid uracil, thus enabling selection of the desired cells.
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1.3.3

IRES in Yeast
Although many functioning eukaryotic IRES elements had been found, successful

internal ribosomal entry had not been reported in yeast until Thompson et al. (2001)
reported efficient translation of the second gene in a bicistronic reporter in S. cerevisiae,
through the use of the CrPV IRES. Although the authors reported poor translation
efficiency in WT cells, they found that cap-independent translation was markedly
increased in the H2545 strain (Dever et al., 1995), which contains disrupted imt3 and
imt4 genes, encoding for two initiator tRNAs. Disrupting expression of these two
tRNAmet genes decreases the intracellular concentration of the eIF2•GTP•Met–tRNAiMet
ternary complex, enhancing the rate of cap-independent translation.

1.4

THESIS OBJECTIVE
This work focuses on the investigation of the effect of artificially-installed

xrRNAs into previously-characterized splicing reporters (Mayas et al., 2010), through
transformation of S. cerevisiae cells with reporters with and without functioning xrRNAs
and IRES elements. In vivo assays examine enzymatic activity in the cells, as well as
quantify relative protein and RNA transcript content upon transformation with the
different reporters. Through these experiments designed to prove the behavior of the
reporters, this work aims to answer the fundamental research question of whether
mRNAs containing artificially-installed xrRNAs can be translated into protein, and
whether they lead to accumulation of decay-resistant transcript and increased levels of
protein expression. The reporter of choice is a bicistronic plasmid containing the ACT1
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gene (and its intron), followed by the LACZ gene. The reporter also contains the URA3
gene as a marker. The xrRNAs have been inserted into the intergenic region, followed by
the CrPV IRES. The two viral elements are hypothesized to be able to work in tandem, to
allow cap-independent translation of the decay-resistant mRNA fragments (FIGURE 6).

FIGURE 6. Translation of partially-decayed messenger RNAs. Addition of the
decay-resistant structures (xrRNAs) to the reporters should result in accumulation of
partially-decayed transcripts. Since these transcripts contain the CrPV IRES structure to
allow for cap-independent translation, translation of partially-decayed mRNAs should
result in increased protein synthesis.

1.4.1

Research Aim 1. Detection of Decay-Resistant Transcripts
RNA transcripts can be quantified directly through primer extension followed by

fragment analysis through capillary electrophoresis. Reverse transcription is initiated by
landing a complementary fluorescently-labeled DNA primer onto the RNA transcripts.
After extension by an RNA-dependent-DNA-polymerase and subsequent degradation of
remaining RNA, complementary DNA (cDNA) is obtained. The cDNA can be analyzed
through capillary electrophoresis. After applying an electric field to the capillary, cDNA
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will travel to the positive electrode with a speed reversely proportional to its length.
Detection of the fluorescently labeled cDNA and integration below the curve of the
corresponding peaks allows for quantification of the nucleic acid at each detected length.

1.4.2

Research Aim 2. Quantification of Enhancement in Protein Expression
Since the LACZ gene is located downstream from the xrRNAs, the protective

effect of these structures from the decay machinery can be examined by comparing the
transcription of the gene in cells expressing reporters with and without the xrRNAs.
Furthermore, since the IRES element should allow for cap-independent translation of the
β-galactosidase enzyme encoded by LACZ, protein expression of β-galactosidase can be
quantified and compared. The activity of β-Galactosidase is commonly quantified
through the β-Galactosidase assay. In vivo, β-Galactosidase is responsible for cleaving
lactose into glucose and galactose. The compound o-nitrophenyl-β-D-galactoside
(ONPG) is also recognized as a substrate and is cleaved into galactose and ο-nitrophenol,
which has an observable yellow color and absorbs light at 420 nm. This allows for both
qualitative and quantitative examination of β-Galactosidase activity in vitro. When cell
lysates are incubated with excess ONPG, the production of o-nitrophenol over time is
proportional to the concentration of β-Galactosidase. This is quantifiable through the
absorbance at 420 nm and normalized by time and initial cell concentration.
While the β-Galactosidase assay can be used to quantify enzymatic activity,
which should be proportional to protein concentration, protein content can be directly
measured through western blotting. Analysis of whole protein cell content can be
24

performed by lysing the cells in order to solubilize cellular proteins in a lysis buffer,
which can subsequently be ran through a gel in order to separate all the proteins by size
using gel electrophoresis. After transfer of the proteins from the gel to a nitrocellulose
membrane, the whole cell protein lysate can be examined for the content of a specific
protein using target-specific antibodies. Through the use of a primary antibody specific to
β-galactosidase, followed by a fluorescently-labeled secondary antibody specific to that
primary antibody, the presence of β-galactosidase can be detected. This allows for the
semi-quantitative analysis of relative protein content with the reporters with and without
the decay-resistant structures.
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CHAPTER 2: MATERIALS AND METHODS
2.1

Strains and Plasmids.

Strain
S288C
H2545

CRY1

CRY1

Reference or
source
Mortimer and
Johnston, 1986
Thomspon et al.,
2001; Dever et al.,
1995
Cherry et al.,
2019; Brickner &
Fuller, 1997
Cherry et al., 2019

CRY1

Cherry et al., 2019

CRY1

Cherry et al., 2019

Relevant Genotype
Parental Strain
MATα SUC2 gal2 mal2 mel
flo1 flo8-1 hap1 ho bio1 bio6
MATa trp1-D1 ura3-52 IMT1
IMT2 imt3::TRP1 imt4::TRP1
leu2::hisG GAL1
MATa ade2-1 can1-100 his3W303-1A
11,15 leu2-3,-112 trp1-1 ura3-1

YJH632

MATa ade2-1 can1-100 his311,15 leu2-3,-112 trp1-1 ura32, xrn1∆::HygMX
YJH898
MATa ade2-1 can1-100 his311,15 leu2-3,-112 trp1-1 ura33, dxo1∆::KanMX
YJH867
MATa ade2-1 can1-100 his311,15 leu2-3,-112 trp1-1 ura34, xrn1∆::HygMX,
dxo1∆::KanMX
TABLE 1. Strains used.

Yeast parental strain S288C was purchased from Fisher Scientific and
manufactured by GE Dharmacon™ (Dharmacon catalog # YSC1060) and was used as a
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reference strain for all knockout-confirmation colony PCR experiments. Strain H2545
was used for all protein expression experiments utilizing the JPS 1480 series reporters, as
well as fragment analysis. β-Galactosidase assay was also performed on CRY1 strains
(Obtained from Patrick D. Cherry) and its derived mutants expressing the JPS 1480 series
reporters (TABLE 1).

FIGURE 7. JPS 1480 series reporters. All plasmids were kindly provided by the
Jonathan P. Staley lab.
JPS 1480 series reporters (FIGURE 7) were obtained from Jonathan P. Staley’s
lab (Mayas et al., 2010). All reporters are bicistronic and include a 5’ m7G cap, the Act1
gene, and the CrPV IRES followed by the LacZ gene and a poly(A) tail (JPS 1481). In
addition, the JPS 1481X reporter contains the xrRNAs immediately preceding the CrPV
IRES. The JPS 1481M reporter contains the sequence for the xrRNAs but with a 3nucleotide mutation along each of the two copies of the pseudo-knots (FIGURE 9) which
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prevent the proper folding of the structures. The JPS 1482 and 1482X reporters contain a
2-nucleotide mutation along the IRES, which render the IRES inactive (FIGURE 2, 9).

2.2

Yeast Husbandry.
All cells were incubated at 30 °C. Liquid cultures were incubated for the specified

amount of time, and all cultures on the surface of plates containing solid media, unless
specified, were grown for 2-3 days. Strain H2545 was grown in complex Yeast Peptone
Dextrose media (YPD), containing 1 g/L bacto yeast extract, 2 g/L peptone, 2 g/L dglucose (dextrose), and 2 g/L agar (for plates only). Solutions were sterilized by
autoclaving. Strains S288C and CRY1 were grown in complex YPD plus Adenine media
(YPAD, which has the same composition of YPD plus 0.004% adenine sulfate
(supplementation with adenine inhibits reversion of ade1 and ade2 mutations present in
CRY1 cells, which cause red coloration on the yeast colonies. Dorfman, 1969). CRY1
knockout strains were grown YPD media supplemented with either 200 µg/mL
Hygromycin B for XRN1 knockouts, or 300 µg/mL G18 for DXO1 knockouts (or both for
ΔXRN1/ΔDXO1).
Uracil auxotrophic strains expressing the JPS 1480 series reporters were grown in
Synthetic Defined media containing 2% d-glucose and lacking uracil (SD/-ura).
Composition of SD/-ura is 5 g/L ammonium sulfate, 1.7 g/L yeast nitrogen base without
amino acids, 2 g/L drop out synthetic mix (-his, -leu, -trp, -ura) without yeast nitrogen
base (US Biological cat. #D9540), 40 mg/L tryptophan, 160 mg/L leucine, 20 mg/L
histidine, and 2 g/L agar for plates. Solutions without amino acids or sugar were
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autoclaved, and supplemented with sterile-filtered stock solutions (4 mg/ml tryptophan
solution, 8 mg/ml leucine solution, 4 mg/ml histidine, 20% (w/v) glucose). Note that if
uracil is added to SD media, it is to a concentration of 20 mg/L.

2.3

Transformation of Yeast Cells
Starter cultures were inoculated with the empty or WT cells and incubated

overnight at 30 °C in 5 mL of the appropriate media (either YPD or YPAD). The
overnight culture was used to seed a new 50 mL culture, which was grown to mid-log
phase. The cells were pelleted at 3068 rcf for 10 minutes and supernatant was discarded.
Cells were resuspended in 50 mL Molecular Biology Grade water (MBG H2O) and
pelleted at 3068 rcf for 10 minutes. After discarding supernatant, cells were resuspended
in 500 µL 100 mM lithium acetate. Suspension was spun down and supernatant was
discarded. Cells were resuspended in 50 µL MBG H2O and 10 µL salmon sperm DNA
were added to spurn recombination. Approximately 1 µg of plasmid DNA was added,
followed by 500 µL PLATE (40% PEG 3350, 100 mM LiOAc, 10 mM TRIS7.5, 0.4 mM
EDTA). The tubes were vortexed to homogenize and heated to 42 °C for 35-40 minutes.
The resulting mixture was used to streak plates containing the selection media, SD/-ura.

2.4

Sequencing
Plasmids were isolated from DH5α E. coli. competent cells previously

transformed with each of the reporters. 5 mL bacterial cultures of LB media (10 g/L
tryptone, 5 g/L yeast extract, and 5 g/L NaCl) supplemented with either 200 µg/mL
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Primer Name
New LacZ PE

Description Sequence (5'-3')
LacZ, front
CCAGGGTTTTCCCAGTCAC
end, reverse
EC JPS series
CrPV IRES, GCTATTTAGCTTTACGTTCCAGG
1480 primer 3
forward
Ana001
ACT1
CTCTCGAGCAATTGGGACCG
intron, front
end, reverse
Ana002
LacZ, Back CGGATTGATGGTAGTGGTCAAATGG
end, forward
Ana003
Cup1, Back CGACGATTCTACTCAGTTTTGAGTACAC
end, forward
Xrn1(YGL173C)B XRN1, front TGTAAAATCGAATTCATATCCAGGT
end (base
122), reverse
D208R3
XRN1, front CGTAAATACAATGTCTCGTATTCTGG
end (base
610), reverse
XRN1 base 1190
XRN1, front GGTTGATGGAGCAATTAC
end (base
1190),
forward
W543-R-AJ
XRN1, front TCAACGTAGTCTTTAGCAAG
end (base
1616),
reverse
Xrn1-Base3034XRN1, back GGGAAGCATATCAATGTTGGTATCCC
AF
end
(base3034),
forward
Xrn1-Base3924XRN1, back GGGATCGCAAAAAGATTCCAAACCC
AF
end
(base3924),
forward
Xrn1(YGL173C)C XRN1, back AGATCAAGGAAGTCGTATTGTTGTC
end (base
4362),
forward
TABLE 2. Primers used for sequencing of JPS 1480 series reporters and pXRN1
(BJH 872).
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ampicillin (for all JPS 1480 reporters) or 100 µg/mL kanamycin (for BJH 872) for
selection, were incubated overnight at 37 °C. Plasmid DNA was isolated using the ZR
Plasmid Miniprep-Classic Kit obtained from Genesee Scientific (Catalog # 11-308A) and
following the protocol specified in the kit. The resulting plasmid was diluted to a
concentration of approximately 80 ng/ µL and mixed with 5 µL of primer at a
concentration of 5 µM (TABLE 2). The samples were submitted for sequencing to
Quintara Biosciences. Data obtained was analyzed using SnapGene®.

2.5

Colony PCR
Cells were grown in the appropriate solid media and incubated at 30 °C for 3

days, until large colonies formed. One large colony (≈1-2 mm in diameter) was
suspended in 50 µL lysis buffer (1% Triton-X 100 (v/v), 20 mM Tris-HCl pH8.5, and 2
mM EDTA in MBG H2O) and heated at 95 °C for 10 minutes. Samples were centrifuged
at 18,407 rcf for 10 minutes to remove cellular debris, and supernatant was transferred to
a new tube. The resulting lysate was used as a template for each PCR reaction.

Target Direction
Sequence (5'-3')
imt3
Forward
GGATTTCATTCTAACACAGCTCAGTGTGC
imt3
Reverse
CCATTAATGAAGTGTTCTATATTGAGGC
imt4
Forward
GCGACATGGAGAGATAGAGATAGAAGAATTTG
imt4
Reverse
CAATTATTAATAATAACGCAGAAGTTAAAGC
XRN1 A-Forward
CCTCCTTTGCTCGTCTTTTCGCCACCACC
XRN1 C-Forward
TTCCAATCATAGGAGAAAACTTCTG
XRN1 D-Reverse
GCGGAAAGCTTTGTGTAAAAAATACCC
DXO1 A-Forward
GGCATTGTTGCATTACAGCGCCAG
DXO1 D-Reverse
GCCATCTTCCAATGTATTCTGGTATCG
TABLE 3. Primers used for colony PCR knockout-confirmation experiments.
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PCR reactions were setup containing: 4 µL of lysate, 2.5 µL 10 mM forward
primer, 2.5 µL 10 mM reverse primer, 20 µL 1.25 mM dNTP mix, 10 µL 5X HF buffer
(ThermoFisher Scientific catalog #F520L), 50 mM MgCl2 (ThermoFisher Scientific
catalog #F518L, to a final concentration of 4 mM), 2.5 µL 0.5 µL 10% Phusion HighFidelity DNA Polymerase (v/v) (ThermoFisher Scientific catalog #F530L), and MBG
H2O to a final volume of 50 µL. Primers used for each template are listed on TABLE 3.
PCR amplification was performed in a thermal cycler programmed at 98 °C for 3 minutes
for initial denaturation; followed by 35 cycles of denaturation at 98 °C for 30 seconds,
annealing for 30 seconds at a temperature gradient of 55-70 °C, and extension at 72 °C
for varying lengths of time for each template; and finalized by extension at 72 °C for 7
minutes. Extension time was 30 seconds for imt3 and imt4, 3 minutes 30 seconds for
XRN1, and 1 minute 30 seconds for DXO1. PCR products were mixed with 10 µL of 6X
loading dye, and separated by electrophoresis at 100V for 1 hour in a 1% (w/v) agarose
gel in Tris-Acetate-EDTA (TAE) buffer containing 0.5 µg/mL ethidium bromide. Gels
were visualized using the Bio-Rad ChemiDoc™ MP Imaging System. Image was
analyzed using Bio-Rad Image Lab™ 6.0 Software and labeled using Microsoft®
PowerPoint®.

2.6

Quantification of Enhancement in Protein Expression

2.6.1 β-Galactosidase Assay
Cells were grown to OD600≈0.5 in the appropriate media. 1.5 ml aliquots were
pelleted and washed with Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1
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mM MgSO4; pH 7.0). Pellet was resuspended in 100 µL of Z-buffer and subjected to
lysis through 6 cycles of freeze-thawing (freezing on liquid N2 followed by thawing in
42°C water bath). Reaction was started through the addition of 700 µL of Z-buffer
containing 1 mg∕mL ortho-nitrophenyl-β−galactopyranoside and 50 mM βmercaptoethanol. After incubation at 30 °C for 3 hours, reaction was quenched by adding
of 500 µL 1M Na2CO3. Cell debris was pelleted and absorbance of the supernatant was
measured at 420 nm using the Tecan Infinite® M1000 plate reader (also used to measure
the initial OD600). Measurements were corrected for activity in wild-type cells and
Miller units were calculated using EQUATION 1 (Miller, 1972).
(EQUATION 1)

2.6.2

𝑀𝑖𝑙𝑙𝑒𝑟 𝑈𝑛𝑖𝑡𝑠 =

𝑂𝐷420 𝑥 1000
𝑂𝐷600 𝑥 𝑇𝑖𝑚𝑒 (𝑚𝑖𝑛)𝑥 𝑉𝑜𝑙 (𝑚𝐿)

Western Blots
Extraction of total yeast cellular protein content was performed as previously

described (Kushnirov, 2000). Specifically, cell cultures were grown to OD600≈0.5, from
which 4-6 mL aliquots were harvested and pelleted by centrifugation. Pellets were
washed with 500 µL of ice-cold water, pelleted and resuspended in 100 µL of water.
Cells were lysed by addition of 100 µL of 0.2 M NaOH and incubation at room
temperature for 10 minutes. Cells were centrifuged at 15,871 rcf for 30 seconds and
supernatant was discarded. Pellet was resuspended in 50 µL of 2x Laemmli Sample
Buffer obtained from Bio-Rad, and 30 µL aliquots were loaded for separation by SDSpage. After electrophoresis, proteins were transferred to a nitrocellulose membrane and
immunoblotted with a rabbit β-galactosidase specific antibody (Novus Biologicals
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catalog number NB300-327) and a rabbit GAPDH specific antibody as a loading control
(Novus Biologicals catalog number NB300-327). Blots were then incubated with a goat
anti-rabbit IgG antibody labeled with StarBright™ Blue 700 dye (Bio-Rad catalog
number 12004162). Detection was performed using the Bio-Rad ChemiDoc™ MP
Imaging System. Image was analyzed using Bio-Rad Image Lab™ 6.0 Software and
labeled using Microsoft® PowerPoint®.

2.7

Detection of Decay-Resistant Transcripts

2.7.1

Fragment Analysis of Primer Extension Products
RNA isolation was performed from cells grown to OD600 between 0.5 and 0.7

and pelleted by centrifugation at 3068 rcf at 4°C. Cells were resuspended in 1000 µL of
cold DNase/RNase-free H2O. Cells were centrifuged for 1 min at 6010 rcf, supernatant
was removed and pellet was frozen on liquid N2. Pellet was thawed on ice and
resuspended in 400 µL cold TES. 400 µL warm acid phenol was added, after which
samples were vortexed for 15 seconds and incubated at 65°C for 30 minutes while
vortexing for 15 seconds every 5 minutes. Samples were transferred to ice and incubated
for 5 minutes, then centrifuged at 1503 rcf at 4°C for 10 minutes. Aqueous (top) layer
was transferred to a new tube and 400 µL chloroform was added. After vortexing for 15
seconds, samples were centrifuged at 18,407 rcf at 4°C for 10 minutes. Aqueous layer
was transferred to a new tube and 40 µL 3M sodium acetate and 1000 µL 100% ethanol
were added. Tubes were inverted to mix and incubated at -80°C for at least 20 minutes.
After incubation, samples were centrifuged at 15,871 rcf at 4°C for 8 minutes.
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Supernatant was carefully removed by micropipette and pellet was washed by adding
cold 70% ethanol and inverting to mix. Samples were again centrifuged at 15,871 rcf at
4°C for 8 minutes and supernatant removed by micropipette. Tubes were inverted and
allowed to fully dry for around 30-60 minutes. The pellet (containing isolated RNA) was
resuspended in 50 µL of DNase/RNase-free molecular-grade H2O, heating to 65°C for 5
minutes if needed. The RNA was stored at -80°C.
The yeast total RNA was diluted to a concentration of 400 ng/µL and reversetranscribed. 12.5 µL of the yeast RNA was mixed
with 2.5 µL hybridization mix (3.75 µM reverse-transcription primer labeled with 6FAM dye in 200 mM Tris pH 8, 200 mM NaCl, 40 mM DTT, can add 1.25 µM of a
secondary primer as a loading control). Reverse transcription primer used was New LacZ
PE (FIGURE S1, TABLE 2). Mixture was folded in the themocycler: 90°C for 3 minutes,
55°C for 3 minutes, 4°C hold. Samples were removed and frozen on liquid N2. 1 µL
GoScript™ Reverse Transcriptase (Promega, catalog number A5003) and 14 µL RT mix
(1.6 mM each dNTP, 10 mM MgCl2, 167 mM Tris pH 8.3, 17mM DTT, 250 mM KCl)
were added. Reverse transcription was performed in the thermocycler: 42°C for 45
minutes, 55°C for 15 minutes, 65°C for 15 minutes, 20°C hold. After reversetranscription, remaining RNA was degraded by the addition of 3 µL 100 mM NaOH and
incubation at 90°C for 3 minutes. Samples were spun down and purified on a G-25
sephedex column (10%w/v beads in H2O). 25 µL formamide was added and samples
were sent for fragment analysis to GeneWiz (Applied Biosystems™ GeneScan™ 600
LIZ™ dye Size Standard added by GeneWiz), or Quintara Biosciences. Capillary
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electrophoresis analysis performed by Quintara Biosciences were performed with either
pre-added ROX 1000 ™, or 600 LIZ™ dye size standard added by Quintara Biosciences
(Both size standards by Applied Biosystems™ GeneScan™). Fragment analysis data was
analyzed using Applied Biosystems™ Peak Scanner™.
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CHAPTER THREE: RESULTS
3.1

Vector Composition
The sequencing results confirmed the presence of all the key elements in the

reporter vectors, shown in FIGURE 8 and FIGURE S1. All vectors feature the
constitutively active, 643-bp-long GAP promoter, followed by the ACT1 gene totaling
394 base pairs, made up of a 5’ UTR, and ORFs A and B separated by an intron. The
ACT1 ORF B is followed by a very short non-coding region (11 bp), which is where the
xrRNAs were inserted into 1481X, 1481M, 1482X and 1482M vectors. The xrRNA
element is composed of two adjacent pseudoknot structures totaling 173 bp in length.
This region is followed by the CrPV IRES element in all the reporter vectors, which is
192 base pairs long and is immediately followed by the LacZ gene. The LacZ ORF is
3,066 bp long and was not fully sequenced. The 5’ and 3’ ends of the ORF were
confirmed by sequencing, but approximately 2,400 bp were left unsequenced. The
remaining sequence (FIGURE 8) was approximated based on homology and assumed to
be present due to the confirmed enzymatic activity in the cells expressing the reporters
(FIGURE 13) and detection of β-galactosidase with protein-specific antibodies (FIGURE
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12), confirming the presence of the fully-functioning protein. The CUP1-1 ORF (182 bp)
that follows is in frame with LacZ and is in turn followed by a non-coding region and the
PGK1 terminator, encoding redundant polyadenylation signals.

FIGURE 8. Map of reporter vectors JPS 1481 (top) and 1481X (bottom),
containing all key features. All reporters contain the following elements, listed in the
5’3’ direction: the GAP promoter (white arrow), ACT1 (black), CrPV IRES (blue),
LacZ (magenta), CUP1-1 (brown), and the PGK1 terminator (yellow). In addition, all
reporters designated as “X” or “M” contain the xrRNAs (red), located between ACT1 and
the CrPV IRES.
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The point mutations corresponding to each mutant structure were also confirmed
by sequencing (FIGURE 8, 9). Each of the two copies of the pseudoknot structure in the
xrRNAs contains a triplet in which each base was mutated to its corresponding canonical
Watson-Crick complementary base (AGTTCA), generating the mutant structure
encoded in JPS 1481M. Similarly, the IRES-dead mutants (1482 and 1482X) contain a
CCGG mutation toward the end of the structure, which was confirmed by sequencing.

xrRNAs 1481X (1-35)
1481M (1-35)

AGGCAAAACTAACATGAAACAAGGCTAAAAGTCAG
AGGCAAAACTAACATGAAACAAGGCTAAATCACAG

1481X (87-121) CAAGGACGTTAAAAGAAGTCAGGCCATCACAAATG
1481M (87-121) CAAGGACGTTAAAAGATCACAGGCCATCACAAATG
IRES

1481 (158-192)
1482 (158-192)

AGATTAGGTAGTCGAAAAACCTAAGAAATTTACCT
AGATTAGGTAGTCGAAAAACCTAAGAAATTTAGGT

FIGURE 9. Sequence alignments of the different JPS 1480 series reporters
confirming the presence of point mutations in the mutant structures. The mutant xrRNAs
contain AGTTCA mutations in bases 30-32 and 103-105 (shown in red, 1481M), and
the mutant CrPV IRES contains a CCGG mutation in bases 190-191 (shown in blue,
1482 and 1482X).

3.2

Methionine Initiator tRNA Genes are Knocked-Out in H2545 Strain
The H2545 laboratory yeast strain was chosen for the investigation of the JPS

1480 series reporters because it had been previously reported to allow for successful capindependent translation (Thompson et al., 2001). The H2545 strain was constructed from
an ascospore cross between two strains, each containing a mutation that inactivated one
of the four IMT (methionine initiator tRNA) genes encoded in the WT strain S288C
(Byström and Fink, 1989; Dever et al., 1995). The resulting H2545 strain thus contains
39

two knocked-out IMT genes, imt3 and imt4. Deletion of these two genes limits the
availability of the eIF2•GTP•Met–tRNAiMet ternary complex in the cell, therefore
reducing the rate of cap-dependent translation and allowing the CrPV IRES to effectively
compete for the translation machinery (Thompson et al., 2001).

FIGURE 10. Colony PCR results confirming that imt3 and imt4 genes are
knocked-out in H2545 yeast, priming that strain for successful cap-independent
translation of the bicistronic reporter. Large individual colonies of S288C and H2545
were resuspended in lysis buffer and lysed by heating to 95 °C. Lysates were used as
templates for PCR amplification using imt3- and imt4-specific primers and subjected to
equal reaction conditions. PCR products were analyzed through gel electrophoresis and
examined for presence of bands at different lengths between the two strains.

In order to experimentally verify that the two initiator methionine genes (imt3 and
imt4) are knocked-out in the H2545 strain, cells were subjected to colony PCR analysis
and compared to the reference strain S288C. The genomic DNA of the H2545 and S288C
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strains was isolated and analyzed via PCR using target-specific primers designed to
amplify the full imt3 and imt4 ORFs. In the WT reference sequence (S288C), PCR
amplification with the designed primers leads to products that are 241 and 247 base pairs
long for imt3 for imt4 respectively. Each imt ORF IS 72 BP long and contains a BssHII
site at position 21, which was digested and used to create the mutants. The restriction site
was filled in with deoxynucleotides, then blunt-end ligated to phosphorylated XhoI
linkers. Similarly, the full TRP1 gene (675 bp long) was obtained by digestion of the
EcoRI-BssHII fragment (890 bp long), which was also filled with deoxynucleotides and
blunt-end ligated to phosphorylated XhoI linkers. The two fragments were digested at the
XhoI site and linked together, resulting in disruption of each imt ORF with the TRP1 gene
(Byström and Fink, 1989). This leads to mutant cells with inactive imt3 and imt4 genes,
but a fully-functioning copy of the TRP1 gene. PCR amplification of the knockout
mutants should result in products with an increased fragment length using the imt3- and
imt4-specific primers, at 1133 bp and 1139 respectively. The colony PCR experiments
results confirm that both methionine initiator tRNA genes are knocked out in the H2545
strain (FIGURE 10).

3.3

Expression of Reporters Containing xrRNAs Yields Decay-Resistant Transcripts
In order to determine if the addition of xrRNAs to the reporters resulted in the

accumulation of decay-resistant fragments, RNA was isolated from whole cell lysates and
subjected to reverse transcription and subsequent fragment analysis by capillary
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electrophoresis. Fragment analysis of cell cultures with the different JPS 1480 series
reporters showed the presence of decay-resistant transcripts containing one and two
A)

B)

FIGURE 11. A) Fragment analysis data showing the presence of transcripts
protected from degradation by one and two copies of the xrRNAs (shown by green box).
MW size standard shown as orange peaks, and corresponding lengths (bp) of the standard
peaks are indicated by black arrows B) Expected fragment length of transcripts
containing the xrRNAs. Total yeast RNA content was isolated and reverse-transcribed
using a fluorescently-labeled primer. The resulting fluorescently-labeled cDNA
fragments were analyzed by capillary electrophoresis. The green arrow illustrates the
approximate binding site of the primer. Results confirm the accumulation of xrRNAprotected fragments.
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copies of the Xrn1-resistant structures, at around 319 and 392 bp respectively, in cells
expressing the JPS 1481X reporter (FIGURE 11). The decay-resistant transcripts were
detected only in the cells expressing the reporter containing the fully-functioning xrRNAs
(red), and not in the mutant (blue), or in the reporter lacking the structure altogether
(black). These xrRNAs, indicated by the green boxes, appear to accumulate in the cells,
as evidenced by the height of the xrRNA protected fragments relative to the height of all
the other peaks of the same color.

JPS
1481

JPS
1481X

JPS
1481M
β-Galactosidase

GAPDH

FIGURE 12. Western Blot of H2545 cells expressing three different reporters
from the JPS 1480 series. Whole cell protein extracts were incubated with either anti-βGalactosidase or anti-GAPDH primary antibodies. A prominent band corresponding to
the molecular weight of β-Galactosidase was observed in the cells expressing the
reporter containing the fully-functioning xrRNAs (1481X), but no significant bands
were observed if the reporter was lacking the xrRNAs (1481) or contained the mutant
copy (1481M). This confirms that addition of the xrRNAs leads to increased protein
expression of the target protein.
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FIGURE 13. Enzymatic activity of β-galactosidase in cell cultures expressing
different reporters from the JPS 1480 series. Total yeast protein lysates were incubated
with ONPG for 3 hours. Enzymatic activity was quantified as absorbance at 420 nm and
normalized for reaction time and initial cell concentration, measured as absorbance at 600
nm. The reporters include either the active form of each element (+), the mutant or
inactive form (-), or are missing the element listed (left blank). Increased enzymatic
activity is only observed upon transformation with reporters with fully-functioning copies
of both xrRNAs and IRES.

3.4

Partially-Decayed Messenger RNAs Are Translated and Lead to Enhanced

Protein Expression.
Through the use of β-Galactosidase-specific antibodies, results show increased
protein content in cell cultures (of comparable cell concentrations as measured by optical
density) containing the decay-resistant structures (FIGURE 12). As seen in Figure 12, the
most prominent band is observed at the correct molecular weight (116 kD) for βGalactosidase only for cells containing the Xrn1-resistant structures.
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The β-Galactosidase Assay also revealed increased enzymatic activity of the cells
expressing the reporters containing the fully-functioning xrRNAs and IRES elements.
After normalization by time and cell concentration (absorbance at 600 nm), as well as
subtracting the enzymatic activity in wild-type cells, addition of Xrn1-resistant structures
resulted in approximately 32-fold increase in enzymatic activity (FIGURE 13, TABLE
S1). Results from the enzymatic activity assay and western blot demonstrate that the
partially-decayed messenger RNAs are successfully translated in the H2545 cells.

3.5

DXO1 knockouts display increased enzymatic activity after transformation with

JPS 1480s series reporters
CRY1 cells (W303-1A) wild-type cells, as well as knockouts for XRN1, DXO1,
and XRN1/DXO1 were transformed with the JPS 1480 series reporters 1481, 1481X, and
1481M. CRY1 cells contain all four IMT genes, suggesting that cap-dependent translation
in these cells should be favored and internal-ribosomal entry should not be observed. βgalactosidase assay was performed on all resulting cells, and the results indicated that
cap-independent translation of the IRES is active in the DXO1 knockout strain, as shown
by the increased enzymatic activity of β-galactosidase in the cells expressing the
functioning xrRNAs (FIGURE 14). The DXO1 knockout expressing the JPS 1481X
reporter was calculated to have an enzymatic activity corresponding to 96.7 Miller Units,
a significant increase compared to the 1.2 Miller Units calculated for the WT strain
expressing the same reporter (FIGURE 14), and the 1.4 Miller Units calculated for the
empty ∆DXO1 cells (FIGURE S3).
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FIGURE 14. β-galactosidase activity of WT CRY1 cells and three different
knockout strains expressing three of the reporters from the JPS 1480 series. Total yeast
protein lysates were incubated with ONPG for 3 hours. Enzymatic activity was quantified
as absorbance at 420 nm and normalized for reaction time and initial cell concentration,
measured as absorbance at 600 nm. β-galactosidase activity of WT CRY1 cells and three
different knockout strains expressing three of the reporters from the JPS 1480 series. The
increased enzymatic activity observed in the DXO1 knockout strain suggests that capindependent translation of the CrPV IRES element is active in this strain.

Surprisingly, the double-knockout cells (∆XRN1/∆DXO1) did not exhibit
increased β-galactosidase activity. In order to genetically rescue the double-knockout
strain, cells were transformed with plasmids containing the full XRN1 ORF. Two
different plasmids were used. The first was a commercial yeast ORF, obtained from
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Dharmacon and containing a (-ura) selective marker (Dharmacon product # YSC3869202330614). The second plasmid was a gift from Jay R. Hesselberth’s lab and contains a
(-leu) selective marker (Plasmid BJH 872). Both sets of cells were tested via βgalactosidase assay but did not demonstrate any increased enzymatic activity compared
to the empty cells (Figure S3). These results indicate that adding the XRN1 ORF to the
∆XRN1/∆DXO1 strain does not genetically rescue IRES activity in this strain.

FIGURE 15. Colony PCR confirmation of ∆XRN1 genotype (xrn1∆::HygMX).
Large individual colonies of wild-type CRY1 cells, as well as knockouts for XRN1,
DXO1 and XRN1/DXO1, were resuspended in lysis buffer and lysed by heating to 95 °C.
Lysates were used as templates for PCR amplification using XRN1-specific primers and
subjected to equal reaction conditions. PCR products were analyzed through gel
electrophoresis. The PCR product obtained at around 2200 bp (left) in the ∆XRN1 and
∆XRN1/∆DXO1 strains confirms that, in these cells, the XRN1 ORF has been replaced
with the HygMX cassette, yielding the knockout genotype. The PCR product observed at
around 460 bp in the CRY1 (and ∆DXO1) cells confirms that the wild-type cells contain
the XRN1 ORF.
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Since genetic rescue of the XRN1/DXO1 knockout strain was unsuccessful, it was
important to confirm the genotype of the cells, as well as the sequence of the pXRN1
plasmid. All four strains were subjected to colony PCR analysis using the target specific
primers listed in TABLE 2.

FIGURE 16. Colony PCR confirmation of the ∆DXO1 genotype
(dxo1∆::KanMX). Large individual colonies of wild-type CRY1 cells, as well as
knockouts for XRN1, DXO1 and XRN1/DXO1, were resuspended in lysis buffer and lysed
by heating to 95 °C. Lysates were used as templates for PCR amplification using DXO1specific primers, subjected to equal reaction conditions, and analyzed through gel
electrophoresis. The results confirm the WT and mutant genotype, as observed in the
difference in length between the PCR products observed at around 1980 bp in the CRY1
(and ∆XRN1) cells and the products observed at around 2000 bp in the two ∆DXO1
strains.

Results from the colony PCR experiments confirm that the XRN1 gene is not
present in the ∆XRN1 and ∆XRN1/∆DXO1 strains, but is present in the WT CRY1 strain
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and the ∆DXO1 strain (FIGURE 15). Primers A and D (left) land in the adjacent regions
of the genome to the XRN1 gene and should yield PCR products corresponding to either
the full XRN1 ORF (plus flanking regions) in the WT cells or the HygMX cassette in the
knockout cells. The full-length product for the WT cells, expected at a length of 5213 bp,
was not observed. The resulting PCR product observed in the knockout cells, at around
2202 bp, corresponds to the expected length and serves as confirmation of the genotype
of the ∆XRN1cells. The genotype of the WT cells was confirmed by using primer C
(right), which lands inside the ORF and should therefore only yield a PCR product (460
bp) in cells that contain the XRN1 ORF.
Similarly, by using primers that land in the flanking regions of the genome to the
DXO1 ORF, the difference in lengths between the WT and knockout strains can be
observed (FIGURE 16). The CRY1 and ∆XRN1 contain the full DXO1 ORF, and
therefore yield PCR products observed at around 1980 bp. In the knockout strains, the
DXO1 ORF has been replaced with the KanMX cassette, which is slightly longer,
resulting in the observed bands at around 2008 bp in the ∆DXO1 and the ∆XRN1/∆DXO1
strains.
Sequencing results of the BJH 872 plasmid encoding for pXRN1 should confirm
that the plasmid encodes for the full-length protein, which should be fully-functioning
(FIGURE S4, pending last sequencing results). The fact that the ∆XRN1/∆DXO1 cells
that were transformed with both the BJH 872 plasmid and the JPS 1480 series plasmids
(either 1481, 1481X, or 1481M) were capable of growing in SD media lacking both
uracil and leucine suggests that the cells were expressing both plasmids simultaneously.
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Since the sequencing results of the BJH 872 plasmid suggest that the plasmid does
encode the full-length protein, the failure to genetically rescue the double-knockout
mutant to behave similarly to the ∆DXO1 mutant is surprising.
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CHAPTER FOUR: DISCUSSION AND SUMMARY
Xrn1 is the major eukaryotic exonuclease and binds to a 5’ monophosphate
substrate exposed after removal of the m7G cap by a decapping enzyme (Dcp1 in yeast).
Xrn1 proceeds in the 5’3’ direction but can be effectively stopped by the pseudoknot
structures encoded in the 3’UTR of the genome of Flaviviruses (Chapman et al., 2014).
These Xrn1-resistant structures, named xrRNAs, have potential therapeutic and industrial
applications, since they can theoretically be used to enhance protein expression of target
genes by protecting them from degradation. Current usage of recombinant DNA
technology includes a wide-range of applications in which target proteins and metabolites
are produced at a large scale in order to improve human health and lifestyle (Khan et al.,
2016). These applications include synthesis of vaccines (Zhang et al., 2011),
pharmaceuticals (Lomedico, 1982), biofuels (Ullah et al., 2015), alternative energy
sources (Tiwari and Pandey, 2012), and could have promising uses in the development of
mRNA therapeutics (Zhong et al., 2018). Using a combination of existing recombinant
DNA technology with xrRNAs can substantially increase the effectiveness of these and
many other applications.
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Our results support the hypothesis that artificially-installed Xrn1-resistant
structures protect RNA transcripts and lead to increased expression of downstream genes
(FIGURES 12, 13, 14, S3). The β-galactosidase assay indicates an average 32-fold
increase in enzymatic activity in cells expressing the decay-resistant structures, compared
to cells expressing the reporter without the decay-resistant structures (FIGURE 13,
TABLE S1). Interestingly, there is a small increase in enzymatic activity (1.25x) found
with the cells expressing the mutant version of the decay-resistant structures, suggesting
the mutant structures provide a small level of protection from degradation. This effect is
consistently observed and should be investigated. The IRES-dead mutants (1482 and
1482X) do not appear to exhibit any increase in enzymatic activity, providing evidence
that the IRES is indeed inactive and cap-independent translation does not occur. Future
directions can include analysis of analogous reporters containing a galactose-inducible
reporter. This should allow for quantification of protein expression over time in order to
compare the difference in the rate of mRNA decay
Fragment analysis results showed the build-up of xrRNA-protected transcripts
containing one and two copies of the viral pseudoknot structure (FIGURE 11). Future
directions can include detection of the longer RNA transcripts (above 500-600 bp), as
well as analysis of the IRES-dead mutants (1482 and 1482X). Since the IRES-dead
mutants contained fully-functioning Xrn1-resistant structures, the length of the transcripts
detected should be identical to those found in the IRES-active reporters. This should
provide evidence that, even in the presence of fully-active Xrn1-resistant structures (and
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therefore an increased concentration of transcripts), increased protein expression is not
possible without also a fully active IRES.
H2545 S. cerevisiae cells are ideal for the investigation of reporters including the
CrPV IRES, since they contain genetic mutations that have been shown to be conducive
to successful cap-independent translation via internal-ribosomal entry (Thompson et al.,
2001). Our results confirm that IRES-dependent translation is active in these cells
(FIGURE 13). Our results also show that the two artificially-installed viral structures
(xrRNAs and CrPV IRES) work in tandem, since the reporters were successfully
transcribed and translated (FIGURES 11 and 13).
In order to examine the effect of the deletion of genes XRN1 and DXO1 in the rate
of cap-independent translation, a different strain was used, whose wild-type cells were
expected to show no IRES activity. β-galactosidase assay results of the empty wild-type
CRY1 cells, as well as the empty knockout cells, served as a control and established the
basal level of enzymatic activity in this strain (FIGURE S3). As expected, after
transformation with the JPS 1481X reporter, the wild-type CRY1 cells did not show
increased enzymatic activity when compared to the empty cells, confirming that the
CrPV structure encoded in the reporter does not successfully initiate translation in the
wild-type cells. However, when the DXO1 gene is deleted, we saw an average 64-fold
increase in enzymatic activity (FIGURE S3, 96.7 Miller units) in the cells expressing the
JPS 1481X reporter when compared to the empty cells (1.2 Miller units in CRY1 cells
and 1.4 Miller units in DXO1). Therefore, our results show that deletion of DXO1
changes cellular conditions enough to allow for successful IRES-dependent translation.
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Thompson et al. reported that the CrPV IRES functioned successfully in cells that had
lower cellular concentrations of the eIF2•GTP•Met–tRNAiMet ternary complex, either due
to the disruption of two initiator tRNAMet genes (cells used in this work), or due to
constitutive expression of the eIF2 kinase GCN2. Our results indicate that deletion of
DXO1 also leads to decreased concentrations of the eIF2•GTP•Met–tRNAiMet ternary
complex.
DXO1 is a predominantly cytoplasmic decapping exonuclease found in some
yeast. This enzyme is involved in mRNA 5’-end-capping quality-control and has 5’3’
exonuclease activity. It has 5’ triophosphonucleotide hydrolase activity and preferentially
decaps transcripts with unmethylated caps. Its exonuclease activity allows it to singlehandedly decap and degrade faulty mRNAs (Chang et al., 2012). Based on current
knowledge, disruption of either the decapping or the exonuclease activity of DXO1
should not decrease the cellular concentration of the eIF2•GTP•Met–tRNAiMet ternary
complex. It remains unclear how deletion of the DXO1 gene leads to the ability of the
knockout cells to successfully initiate translation using the CrPV IRES. Since our results
suggest that deletion of the DXO1 gene makes cap-dependent translation less favorable,
and since it has been shown that DXO1 interacts with the 5’ end of an mRNA, it is
possible that this enzyme plays an additional role in the cell and is somehow involved in
formation of the translation pre-initiation complex.
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APPENDIX A
SUPPLEMENTAL INFORMATION

FIGURE S1. Comprehensive map of reporter vectors JPS 1481 (top) and 1481X
(bottom), containing all key features, restriction enzyme cleavage sites, and primers
used for sequencing (shown by lime green arrows indicating direction of primer).
New LacZ PE primer was also used for reverse transcription.
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30-Aug
JPS 1481
4.37
JPS 1481 X 124.33
JPS 1481 M 3.95
JPS 1482
3.05
JPS 1482 X
2.60

Miller units
31-Aug 8-Sept (1) 8-Sept (2)
6.55
3.20
3.03
155.67
102.00
128.66
6.56
4.57
5.10
6.07
2.31
2.89
4.11
1.17
2.06

Mean
4
128
5
4
2

St Dev
2
22
1
2
1

TABLE S1. Quantitative results of β-galactosidase assay of H2545 cells
expressing different JPS 1480 series reporters. Total yeast protein lysates were
incubated with ONPG for 3 hours. Enzymatic activity was quantified as absorbance
at 420 nm and normalized for reaction time and initial cell concentration, measured
as absorbance at 600 nm.

FIGURE S2. Qualitative results of β-galactosidase assay of H2545 cells
expressing different. The tubes, listed from left-to-right, belong to cells expressing
the following JPS 1480 series reporters: 1481, 1481X, 1481M, 1482, 1482X, and
empty cells. As results indicate, cells containing the IRES-dead elements have close
to the same enzymatic activity as the empty cells (1482, 1482X). The cells
containing the functioning IRES but inactive xrRNAs have some increased activity,
as evidenced by the light yellow color (1481, 1481M). The cells with the highest
activity are those in which both elements are active (1481X, second tube from the
left).
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FIGURE S3. β-galactosidase activity of WT CRY1 cells and three different
knockout strains expressing three of the reporters from the JPS 1480 series, and the
double-knockout strains also expressing two different plasmids containing the XRN1
ORF. Only the DXO1 knockout appears to have increased enzymatic activity when
compared to the empty cells, suggesting that adding the XRN1 ORF to the doubleknockout strain does not genetically rescue IRES activity. The activity of empty cells was
also tested to establish a reference point of enzymatic activity.

FIGURE S4. Sequencing map of BJH 872 plasmid, encoding pXRN1. Map shows
entire length of yeast wild-type XRN1gene (black line). Colored arrows indicate fragment
that was sequenced using each corresponding primer, as well as direction of the primer.
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